Related Experiment Video
Updated: Aug 13, 2026

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development
Renée V Hoch1, Philippe Soriano
1Program in Developmental Biology, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.
Abstract:
Fibroblast growth factor receptor 1 (Fgfr1) plays pleiotropic roles during embryonic development, but the mechanisms by which this receptor signals in vivo have not previously been elucidated. Biochemical studies have implicated Fgf receptor-specific substrates (Frs2, Frs3) as the principal mediators of Fgfr1 signal transduction to the MAPK and PI3K pathways. To determine the developmental requirements for Fgfr1-Frs signaling, we generated mice (Fgfr1(Delta)Frs/DeltaFrs) in which the Frs2/3-binding site on Fgfr1 is deleted. Fgfr1(Delta)Frs/DeltaFrs embryos die during late embryogenesis, and exhibit defects in neural tube closure and in the development of the tail bud and pharyngeal arches. However, the mutant receptor is able to drive Fgfr1 functions during gastrulation and somitogenesis, and drives normal MAPK responses to Fgf. These findings indicate that Fgfr1 uses distinct signal transduction mechanisms in different developmental contexts, and that some essential functions of this receptor are mediated by Frs-independent signaling.
Insights
Fibroblast growth factor receptor 1 (Fgfr1) signaling is essential for embryonic development. Some Fgfr1 functions rely on Frs2/3-dependent pathways, while others utilize Frs-independent signaling.
Area of Science:
- Developmental biology
- Molecular signaling
- Genetics
Background:
- Fibroblast growth factor receptor 1 (Fgfr1) has critical roles in embryonic development.
- Fgf receptor-specific substrates (Frs2, Frs3) are known mediators of Fgfr1 signaling to MAPK and PI3K pathways.
Purpose of the Study:
- To investigate the in vivo signaling mechanisms of Fgfr1 during embryonic development.
- To determine the necessity of Frs2/3 binding for Fgfr1 function.
Main Methods:
- Generation of Fgfr1(Delta)Frs/DeltaFrs mutant mice lacking the Frs2/3-binding site on Fgfr1.
- Analysis of embryonic development, including neural tube closure, tail bud, and pharyngeal arch formation.
- Assessment of Fgfr1 signaling via MAPK pathway activation.
Main Results:
- Fgfr1(Delta)Frs/DeltaFrs embryos exhibit embryonic lethality during late embryogenesis.
- Mutant embryos show defects in neural tube closure, tail bud, and pharyngeal arch development.
- The mutant receptor retains Fgfr1 functions during gastrulation and somitogenesis, and supports normal MAPK signaling.
Conclusions:
- Fgfr1 utilizes distinct signal transduction pathways in different developmental stages.
- Essential embryonic functions of Fgfr1 can be mediated independently of Frs2/3 binding.
- This highlights the complexity of Fgfr1 signaling in vivo.
Related Concept Videos
Determination
Non-Canonical Wnt Signaling Pathways

